The Financial Express2d
Dividend stocks checklist: 5 stocks to watch out for dividends in April 2025
The Board of Directors, in a meeting held on 25 March 2025, declared an interim dividend of Rs 25 per equity share on a face ...
US FDA approves Sanofi's bleeding disorder therapy
The U.S. Food and Drug Administration approved French drugmaker Sanofi's hemophilia therapy, introducing a new type of ...
Fierce Pharma2d
Sanofi's versatile Qfitlia scores FDA nod to enter crowded hemophilia market
Over the last three years, the FDA has approved six new hemophilia drugs, including three gene therapies. | Over the last ...
Endpoints News2d
FDA ap­proves Sanofi's RNAi drug for he­mo­phil­ia A and B
FDA approves Sanofi's RNAi hemophilia drug fitusiran, licensed from Alnylam, to treat both hemophilia A and B by lowering ...